创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology ELISA Platform: A Powerful Tool to Precisely Analyze Biomolecular Interactions

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-19 14:10
  • Views:

(Summary description)Enzyme-linked immunosorbent assay (ELISA) has become a crucial technique in biological science and medical research, and is widely used for the qualitative and quantitative analysis of biomolecules such as proteins, antibodies and antigens. With its unique features, InnoModels Bio's ELISA platform provides researchers with accurate, reliable and efficient testing solutions.

InnoModels Biotechnology ELISA Platform: A Powerful Tool to Precisely Analyze Biomolecular Interactions

(Summary description)Enzyme-linked immunosorbent assay (ELISA) has become a crucial technique in biological science and medical research, and is widely used for the qualitative and quantitative analysis of biomolecules such as proteins, antibodies and antigens. With its unique features, InnoModels Bio's ELISA platform provides researchers with accurate, reliable and efficient testing solutions.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-19 14:10
  • Views:
Information

Enzyme-linked immunosorbent assay (ELISA) has become a crucial technique in biological science and medical research, and is widely used for the qualitative and quantitative analysis of biomolecules such as proteins, antibodies and antigens. With its unique features, InnoModels Bio's ELISA platform provides researchers with accurate, reliable and efficient testing solutions.
1. High specificity and sensitivity
InnoModels' ELISA platform combines high-quality antigens, antibodies and optimized detection steps to ensure highly specific recognition of target biomolecules. At the same time, through precise signal amplification and detection, the platform realizes highly sensitive detection of biomolecules, allowing accurate results to be obtained even at extremely low concentrations of the target molecule in the sample.
2. Wide applicability
InnoModels' ELISA platform can be applied to the detection of many types of biomolecules, including, but not limited to, proteins, antibodies, antigens, cytokines, hormones, and so on. In addition, the platform supports the detection of a wide range of sample types, such as serum, plasma, cell culture supernatant, tissue homogenate, etc., providing great flexibility for researchers.
3. Reliability and Stability
During the development and production of ELISA kits, InnoModels Biotechnology strictly controls the quality of raw materials, the stability of the production process, and the consistency between batches to ensure the reliability and stability of the test results. Researchers can safely rely on this platform for repetitive experiments and large-scale sample screening.

 


4. Simple operation process
InnoModels Bio's ELISA platform adopts optimized experimental design and simple operation procedure, which makes the experimental steps easier and faster. Researchers can complete the experimental operation in a short period of time, which improves work efficiency and reduces experimental errors and variability.
5. Quantitative Analysis
In addition to qualitative analysis, InnoModels' ELISA platform also provides accurate quantitative analysis. Through the establishment and analysis of the standard curve, the concentration of the target biomolecule in the sample can be accurately calculated, providing researchers with more detailed data support.
6. Good reproducibility and comparability
InnoModels' ELISA platform emphasizes on the reproducibility of the test results, ensuring good comparability of the test results at different times, in different batches and under different laboratory conditions. This helps researchers to analyze and compare data under different experimental conditions, which improves the reliability and persuasiveness of the research.
Summary
With its high specificity, high sensitivity, broad applicability, reliability and stability, easy operation procedure, quantitative analysis capability, and good reproducibility and comparability, InnoModels' ELISA platform has become a powerful tool for researchers to carry out biomolecular assays. This platform has a promising application in life science, medicine, drug development and other fields, and will play an important role in promoting the progress and development of related fields.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司